-
A Peek Into The Market Before The Trading Starts
Wednesday, April 27, 2011 - 7:28am | 453Pre-open movers US stock futures are higher this morning, as investors are awaiting Federal Reserve Chairman's news conference. Futures on the Dow Jones Industrial Average gained 40 points to 12,558.00 and S&P 500 index futures rose 4.90 points to 1,345.80. Futures on the Nasdaq 100 surged 15....
-
Vical Announces Encouraging H1N1 Pandemic Influenza Vaccine Phase 1 Results (VICL)
Wednesday, April 27, 2011 - 6:55am | 94Vical Incorporated (NASDAQ: VICL) announced today that more than half of the subjects in the Phase 1 trial of the company's Vaxfectin(R)-formulated vaccine for H1N1 pandemic influenza generated neutralizing antibodies of the type expected to provide protection against the disease. The vaccine was...
-
Piper Jaffray Raises PT On Regeneron Pharmaceuticals To $62
Wednesday, April 27, 2011 - 6:51am | 27Piper Jaffray has raised the price target on Regeneron Pharmaceuticals (NASDAQ: REGN) from $51 to $62 and maintains its Overweight rating.
-
Regeneron Pharmaceuticals Jumps 14% After Halt (REGN)
Tuesday, April 26, 2011 - 4:39pm | 260Regeneron Pharmaceuticals (NASDAQ: REGN) resumed trading today at 4:35pm. The stock price has jumped over 14% from the close on positive cancer news. Sanofi-aventis Regeneron Pharmaceuticals today announced that the Phase III VELOUR trial evaluating the investigational agent ZALTRAP (aflibercept...
-
Sanofi-aventis and Regeneron Report Positive Phase III Results With ZALTRAP in Second-line Metastatic Colorectal Cancer
Tuesday, April 26, 2011 - 4:14pm | 112Sanofi-aventis (NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced that the Phase III VELOUR trial evaluating the investigational agent ZALTRAP™ , also known as VEGF Trap, in combination with the FOLFIRI chemotherapy regimen, 5-fluorouracil, and irinotecan] versus a...
-
Sanofi-aventis and Regeneron Report Positive Phase III Results With ZALTRAP™ (SNY, REGN)
Tuesday, April 26, 2011 - 4:09pm | 78Sanofi-aventis (NYSE: SNY) and Regeneron Pharmaceuticals (Nasdaq: REGN) today announced that the Phase III VELOUR trial evaluating the investigational agent ZALTRAP™ , also known as VEGF Trap, in combination with the FOLFIRI chemotherapy regimen [folinic acid, 5-fluorouracil, and irinotecan] versus...
-
CryoPort (OTCBB: CYRX) Named to OC METRO's 2011 Green Team
Tuesday, April 26, 2011 - 4:02pm | 683CryoPort Inc. (OTCBB: CYRX), a provider of technology-driven transport and packaging systems focused on helping companies similar to Life Sciences Technology Corp. (NASDAQ: LIFE) and Global Health Inc. (NASDAQ: GHDX), was recently named to OC METRO's 2011 Green Team. CryoPort, Inc. (OTCBB: CYRX)...
-
Vertex Stock Booms After FDA Reports New Drug is Effective (VRTX)
Tuesday, April 26, 2011 - 2:00pm | 221Vertex (NASDAQ: VRTX) is up more than 10% today on news that the FDA found the pharmaceutical company's Hepatitis C drug was more effective than current drugs on the market. The announcement on the efficacy of telaprevir comes ahead of Thursday's meeting, where the FDA is expected to vote on...
-
Calls Purchased on BioSante Pharmaceuticals, Inc. (BPAX)
Tuesday, April 26, 2011 - 1:47pm | 114Shares of BioSante Pharmaceuticals, Inc. (NYSE: BPAX) are higher on the session by 2.97%, currently trading at $2.18. The stock has been moving largely higher over the past six months and is currently trading above the 50-day moving average. Options traders are buying calls on the name today. A...
-
Puts Purchased on United Therapeutics Corporation (UTHR)
Tuesday, April 26, 2011 - 1:08pm | 137Shares of United Therapeutics Corporation (NASDAQ: UTHR) are higher on the session by 0.61%, currently trading at $70.43. The stock has been moving largely higher over the past five months and is currently trading above the 50-day and 200-day moving averages. Options traders are buying puts on...
-
Options Brief: Celsion Corporation (CLSN)
Tuesday, April 26, 2011 - 11:53am | 103Shares of Celsion Corporation (NASDAQ: CLSN) are higher on the session by 9.43%, trading at $2.67. Overall put volume is now running at 107.14x the daily average, with 0% of all puts traded being purchases on the offer. 3,000 contracts have traded on the session so far. Celsion Corporation is an...
-
Options Brief: Arena Pharmaceuticals (ARNA)
Tuesday, April 26, 2011 - 11:32am | 85Shares of Arena Pharmaceuticals (NASDAQ: ARNA) are higher on the session by 12.60%, trading at $1.43. Overall call volume is now running at 3.11x the daily average, with 88% of all calls traded being purchases on the offer. 2,000 contracts have traded on the session so far. Arena Pharmaceuticals...
-
Vertex Jumps Over 13% Higher After FDA Results (VRTX)
Tuesday, April 26, 2011 - 10:51am | 17Vertex (NASDAQ: VRTX) Jumps Over 13% Higher After FDA Results
-
Update: Vertex Hepatitis C Drug is Effective -Bloomberg (VRTX)
Tuesday, April 26, 2011 - 10:45am | 30Bloomberg reports that FDA says, "Vertex (NASDAQ: VRTX) Hepatitis C drug is effective... side effects include rash, anemia... drug cures more patients."
-
Vertex Hepatitis C Drug Is Effective, FDA Reviewers Say -Bloomberg (VRTX)
Tuesday, April 26, 2011 - 10:34am | 20Vertex Pharmaceuticals (NASDAQ: VRTX) Hepatitis C drug is effective, FDA reviewers say.